Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- PMID: 32376597
- DOI: 10.1136/annrheumdis-2020-217706
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
Keywords: antirheumatic agents; biological therapy; cytokines; interleukin 1 receptor antagonist protein; therapeutics.
Conflict of interest statement
Competing interests: AA, outside of this work, obtained non-financial support for research in giant cells arteritis with Anakinra from SOBI Phramaceutics, .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources